Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Mayo Clinic unveils breakthrough tool for hidden cancer DNA analysis
BACDAC, Mayo Clinic, /in E-News, Genetics, Oncology /by panglobalMayo Clinic researchers have developed BACDAC, a computational tool that exposes elusive genomic patterns in cancer samples with low DNA coverage, with the aim of transforming how clinicians predict tumour behaviour and guide personalised treatment decisions through enhanced detection of chromosomal instability markers.
NEFECON receives Chinese approval for expanded IgA nephropathy treatment
IgA nephropathy, immunomodulatory treatment, /in E-News, pharmacology /by panglobalChina’s National Medical Products Administration has approved expanded production capacity for NEFECON®, the only etiological treatment for IgA nephropathy. The regulatory milestone addresses growing clinical demand across Asia, where over 5 million patients live with this progressive kidney disease requiring targeted therapeutic intervention.
25-year study reveals how SuperAgers defy cognitive decline
SuperAgers, /in Ageing, Featured Articles, Mental health, Research /by panglobalTwenty-five years of Northwestern University research reveals that adults over 80 with exceptional memory possess unique brain structures, greater resistance to Alzheimer’s pathology, and enhanced cellular characteristics that challenge traditional assumptions about cognitive decline during normal ageing processes in humans.
15 minutes in city green space proves powerful antidote to anxiety and depression
urban forests, wellbeing, /in E-News, Mental health /by panglobalA comprehensive global analysis of nearly 6,000 participants reveals that brief exposure to urban nature provides substantial mental health benefits, with urban forests emerging as particularly powerful environments for psychological wellbeing. The research offers evidence-based guidance for integrating green spaces into public health strategies.
Gates Foundation commits $2.5 billion to transform women’s health research
Gates Foundation, /in E-News, Women's Health /by panglobalThe Gates Foundation announces unprecedented $2.5 billion investment through 2030 to accelerate research and development in chronically underfunded women’s health areas, targeting maternal, menstrual, gynaecological, and sexual health innovations for global impact, particularly in low- and middle-income countries.
Breakthrough brain imaging technology reveals neurovascular dynamics at cellular resolution
brain, /in E-News, Imaging /by panglobalChinese researchers have developed a revolutionary hybrid microscope that simultaneously captures brain blood flow and neuronal activity across the entire mouse cortex with unprecedented detail. The LiTA-HM system achieves subcellular resolution over a 6mm field of view, opening new frontiers in neurovascular coupling research and brain-computer interface development.
Non-autoimmune diabetes discovered in African children challenges type 1 classification
Africa, children, /in Diabetes, E-News, Research /by panglobalA landmark multi-country study has uncovered compelling evidence that the majority of children and young adults clinically diagnosed with type 1 diabetes across sub-Saharan Africa actually have a previously unrecognised non-autoimmune form of insulin-deficient diabetes. The research fundamentally challenges current diabetes classification systems and could change treatment approaches for young people with diabetes in Africa […]
New AI-powered exoskeletons poised to transform rehabilitation autonomy
exoskeleton, /in AI, E-News, Rehabilitation /by panglobalArtificial intelligence could unlock the full potential of therapeutic and assistive exoskeletons by enabling autonomous operation, reducing dependence on therapists and caregivers. However, researchers emphasise that richer patient data and more accurate digital twins are essential before these technologies can achieve widespread clinical deployment and revolutionise rehabilitation outcomes.
New microfluidic device generates high-quality platelet-rich plasma
blood platelets, MedTech, /in Diabetes, E-News /by panglobalResearchers at the University of the Basque Country have developed a groundbreaking microfluidic device that efficiently extracts platelet-rich plasma (PRP) from whole blood using gravity sedimentation, achieving significantly lower platelet activation rates than conventional centrifugation methods whilst maintaining high purity levels.
New lung-on-chip technology with iPS cells reveals distinct immune responses for flu and COVID-19
influenza, lung-on-chip, SARS-CoV-2, /in COVID 19, E-News, Research /by panglobalScientists have developed groundbreaking airway and alveolus chip models using induced pluripotent stem cells, revealing how SARS-CoV-2 and influenza trigger dramatically different immune responses in upper versus lower respiratory regions. The research offers new insights into COVID-19 pathology and potential therapeutic targets.